Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.9 USD | +20.61% | -2.47% | +558.33% |
Business Summary
Number of employees: 8
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Natural Bioactive Ingredients
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Payne
CEO | Chief Executive Officer | 76 | 18/07/13 |
Keith Marchiando
DFI | Director of Finance/CFO | 61 | 31/12/20 |
Laura Belicka
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/21 |
Harlan L. Miller
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 30/04/13 | |
William P. Pfund
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 16/09/14 | |
Director/Board Member | 58 | 27/08/13 | |
John Payne
CEO | Chief Executive Officer | 76 | 18/07/13 |
Alison Cornell
BRD | Director/Board Member | 62 | 07/02/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,802,988 | 1,675,876 ( 59.79 %) | 0 | 59.79 % |
Company contact information
Zivo Bioscience, Inc.
21 East Long Lake Road Suite 100
48304, Bloomfield Hills
+(248) 452 9866
http://www.zivobioscience.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+558.33% | 22.14M | |
+13.21% | 8.15B | |
+3.16% | 7.52B | |
+12.30% | 6.65B | |
-5.71% | 3.73B | |
-6.99% | 3.72B | |
-4.78% | 1.31B | |
+12.61% | 972M | |
-37.22% | 958M | |
-15.02% | 876M |
- Stock Market
- Equities
- ZIVO Stock
- Company ZIVO Bioscience, Inc.